3/27/25 08:13 | 3/26/25 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Reynolds Cameron John | NV | DO | P,CEO | P | 100 | 0.5500 | 0 | 182 | 6 | 3,341 | D | | | | | | | | | | | | | | |
3/27/25 08:13 | 3/26/25 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Innes Guy Archibald | NV | D | | P | 100 | 0.5500 | 0 | 182 | 6 | 3,243 | D | | | | | | | | | | | | | | |
3/19/25 16:38 | 3/17/25 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Oki Mark K | WA | O | CFO | P | 29 | 2.89 | 0 | 10 | New | 10 | D | | | | | | | | | | | | | | |
3/19/25 16:32 | 3/17/25 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Stewart Richard Alistair | WA | DO | Chieve E | P | 29 | 2.86 | 0 | 10 | 19 | 62 | D | | | | | | | | | | | | | | |
2/11/25 19:00 | 2/7/25 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | James Andrea S. | CA | O | CFO | P | 200 | 2.05 | 0 | 98 | 182 | 151 | D | | | | | | | | | | | | | | |
2/11/25 17:00 | 2/7/25 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Smith Patrick W | CA | T | | P | 2,209 | 2.05 | 0 | 1,078 | 49 | 3,258 | I | | | | | | | | | | | | | | |
2/10/25 20:43 | 2/6/25 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Broadwood Partners, L.P. | NY | T | | P.d | 10,590 | 2.05 | 0 | 5,166 | 29 | 22,820 | M | | | | | | | | | | | | | | |
2/4/25 16:45 | 1/31/25 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Smith Patrick W | CA | T | | P.m | 2 | 2.01 | 0 | 1 | 0 | 1,795 | I | | | | | | | | | | | | | | |
1/31/25 17:00 | 1/29/25 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Smith Patrick W | CA | T | | P.m | 8 | 2.01 | 0 | 4 | 0 | 1,794 | I | | | | | | | | | | | | | | |
1/16/25 15:28 | 1/16/25 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Naemura David H. | MI | O | CFO | P | 164 | 11.11 | 0 | 15 | 32 | 61 | D | | | | | | | | | | | | | | |
1/16/25 12:05 | 1/16/25 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Adent John Edward | MI | O | CEO | P | 254 | 11.03 | 0 | 23 | 9 | 269 | D | | | | | | | | | | | | | | |
1/15/25 17:00 | 1/13/25 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Smith Patrick W | CA | T | | P.m | 34 | 2.12 | 0 | 16 | 1 | 1,790 | I | | | | | | | | | | | | | | |
12/27/24 21:49 | 12/26/24 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Smith Patrick W | CA | T | | P | 192 | 2.13 | 0 | 90 | 5 | 1,774 | I | | | | | | | | | | | | | | |
12/26/24 18:17 | 12/26/24 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Arno Andrew | CA | D | | P | 26 | 2.11 | 0 | 13 | 15 | 97 | D | | | | | | | | | | | | | | |
12/13/24 16:12 | 12/11/24 | QDEL | Quidelortho Corp | | Health | Diagn | In Vitro & In Vivo Diagnostic | Blaser Brian J. | CA | O | P,CEO | P | 250 | 41.42 | 0 | 6 | New | 6 | I | | | | | | | | | | | | | | |
12/10/24 16:01 | 12/9/24 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Innes Guy Archibald | NV | D | | P | 100 | 0.5722 | 0 | 175 | 6 | 2,991 | D | | | | | | | | | | | | | | |
12/10/24 16:01 | 12/9/24 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Still Timothy I | NV | D | | P | 50 | 0.5722 | 0 | 87 | 6 | 1,487 | D | | | | | | | | | | | | | | |
12/10/24 16:01 | 12/9/24 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Micallef Jacob Vincent | NV | O | Chief Sc | P | 25 | 0.5722 | 0 | 44 | 10 | 487 | D | | | | | | | | | | | | | | |
12/10/24 16:01 | 12/9/24 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Reynolds Cameron John | NV | DO | P,CEO | P | 80 | 0.5722 | 0 | 140 | 5 | 3,159 | D | | | | | | | | | | | | | | |
12/9/24 08:00 | 12/5/24 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | James Andrea S. | CA | O | CFO | P | 46 | 2.29 | 0 | 20 | 59 | 54 | D | | | | | | | | | | | | | | |
11/12/24 08:01 | 11/11/24 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Marucci Anthony S | NJ | DO | P,CEO | P | 308 | 26.82 | 0 | 12 | 40 | 40 | D | | | | | | | | | | | | | | |
10/15/24 09:21 | 10/11/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Adent John Edward | MI | O | CEO | P | 200 | 13.80 | 0 | 15 | 7 | 216 | D | | | | | | | | | | | | | | |
10/9/24 13:18 | 9/6/24 | CDIO | Cardio Diagnostics Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Dogan Timur | IL | O | CTO | P.a | 20 | 0.2900 | 0 | 69 | 54 | 197 | D | | | | | | | | | | | | | | |
10/8/24 10:42 | 9/6/24 | CDIO | Cardio Diagnostics Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Dogan Meeshanthini | IL | DO | CEO | P.a | 20 | 0.2900 | 0 | 69 | 4 | 1,655 | D | | | | | | | | | | | | | | |
10/7/24 11:29 | 9/6/24 | NUTX | Cardio Diagnostics Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Dogan Meeshanthini | IL | DO | CEO | P.a | 20 | 0.2900 | 0 | 69 | 4 | 1,655 | D | | | | | | | | | | | | | | |
10/4/24 19:40 | 10/2/24 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | James Andrea S. | CA | O | CFO | P | 100 | 2.97 | 0 | 34 | New | 34 | D | | | | | | | | | | | | | | |
10/4/24 19:00 | 10/2/24 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Broadwood Partners, L.P. | NY | T | | P.d | 3,878 | 2.95 | 0 | 1,315 | 12 | 12,489 | M | | | | | | | | | | | | | | |
9/23/24 16:24 | 9/6/24 | NUTX | Cardio Diagnostics Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Dogan Timur | IL | O | CTO | P.a | 20 | 0.2900 | 0 | 69 | 54 | 197 | D | | | | | | | | | | | | | | |
9/10/24 17:22 | 9/6/24 | CDIO | Cardio Diagnostics Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Philibert Robert | IL | DO | Chief Me | P | 10 | 0.2865 | 0 | 34 | 2 | 1,684 | I | | | | | | | | | | | | | | |
9/9/24 11:08 | 9/6/24 | CDIO | Cardio Diagnostics Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Dogan Meeshanthini | IL | O | CTO | P | 20 | 0.2900 | 0 | 69 | 54 | 197 | D | | | | | | | | | | | | | | |
9/9/24 11:01 | 9/6/24 | CDIO | Cardio Diagnostics Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Dogan Meeshanthini | IL | DO | CEO | P | 20 | 0.2900 | 0 | 69 | 4 | 1,684 | D | | | | | | | | | | | | | | |
8/21/24 08:26 | 8/20/24 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Innes Guy Archibald | NV | D | | P | 101 | 0.6700 | 0 | 150 | 6 | 2,781 | D | | | | | | | | | | | | | | |
8/7/24 10:17 | 8/6/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Tobin James P | MI | D | | P | 51 | 16.86 | 0 | 3 | 15 | 23 | D | | | | | | | | | | | | | | |
7/16/24 21:13 | 7/12/24 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Telegraph Hill Partners Iv, L.P. | CA | T | | P | 15,000 | 1.24 | 0 | 12,097 | 83 | 26,591 | I | | | | | | | | | | | | | | |
7/16/24 17:15 | 7/12/24 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Lowell Matthew | CA | O | CFO | P | 50 | 1.24 | 0 | 40 | 46 | 128 | D | | | | | | | | | | | | | | |
7/16/24 17:15 | 7/12/24 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Gunstream Stephen | CA | DO | P,CEO | P | 100 | 1.24 | 0 | 81 | 50 | 243 | D | | | | | | | | | | | | | | |
7/11/24 17:15 | 7/9/24 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Schuler Jack W | IL | T | | P.d | 0 | 0.00 | 0 | 7 | 0 | 1,919 | D | | | | | | | | | | | | | | |
6/18/24 16:12 | 1/26/24 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Schuler Jack W | IL | T | | P.d | 0 | 0.00 | 0 | 29 | 2 | 1,912 | I | | | | | | | | | | | | | | |
6/3/24 17:30 | 5/31/24 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sandford Nicole | TX | DO | CEO | P | 23 | 2.42 | 0 | 9 | 16 | 71 | D | | | | | | | | | | | | | | |
4/17/24 12:04 | 4/17/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Jones Douglas Edward | MI | O | COO | P | 124 | 12.36 | 0 | 10 | 28 | 46 | D | | | | | | | | | | | | | | |
4/15/24 19:21 | 4/11/24 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Broadwood Partners, L.P. | NY | T | | P.d | 7,058 | 2.92 | 0 | 2,420 | 33 | 9,858 | M | | | | | | | | | | | | | | |
4/15/24 06:04 | 4/11/24 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Riggs Josh | CA | DO | CEO,P | P | 10 | 2.95 | 0 | 3 | 999% | 4 | D | | | | | | | | | | | | | | |
4/15/24 06:02 | 4/11/24 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Arno Andrew | CA | D | | P | 100 | 2.95 | 0 | 34 | 67 | 85 | D | | | | | | | | | | | | | | |
4/11/24 11:40 | 4/11/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Borel James C | DE | D | | P | 98 | 13.06 | 0 | 8 | 54 | 21 | D | | | | | | | | | | | | | | |
4/10/24 16:18 | 4/10/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Naemura David H. | MI | O | CFO | P | 156 | 12.51 | 0 | 13 | 71 | 30 | D | | | | | | | | | | | | | | |
4/10/24 14:25 | 4/10/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Adent John Edward | MI | O | CEO | P | 284 | 12.36 | 0 | 23 | 18 | 152 | D | | | | | | | | | | | | | | |
3/8/24 11:24 | 3/6/24 | CATX | Perspective Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Lantheus Alpha Therapy, LLC | MA | T | | P | 57,409 | 0.9500 | 0 | 60,431 | 107 | 116,773 | D | | | | | | | | | | | | | | |
3/6/24 16:49 | 3/4/24 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Stewart Richard Alistair | WA | DO | Exec CB | P.d | 46 | 4.59 | 0 | 10 | 35 | 39 | D | | | | | | | | | | | | | | |
3/6/24 16:43 | 3/4/24 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bencich John | WA | DO | CEO | P.d | 46 | 4.59 | 0 | 10 | 15 | 77 | D | | | | | | | | | | | | | | |
2/27/24 16:21 | 8/15/22 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Grossman Paul David | CA | D | | P.m | 50 | 5.37 | 0 | 9 | New | 9 | D | | | | | | | | | | | | | | |
2/26/24 18:48 | 2/23/24 | QDEL | Quidelortho Corp | | Health | Diagn | In Vitro & In Vivo Diagnostic | Busky Joseph M | CA | O | CFO | P | 100 | 46.36 | 0 | 2 | 54 | 6 | I | | | | | | | | | | | | | | |
1/30/24 20:31 | 1/26/24 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sandford Nicole | TX | DO | P,CEO | P.d | 0 | 0.00 | 0 | 2 | 4 | 61 | D | | | | | | | | | | | | | | |
12/19/23 10:59 | 12/18/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Butera Salvatore Thomas | NV | O | CEO - Vo | P | 8 | 0.8300 | 0 | 10 | 4 | 278 | D | | | | | | | | | | | | | | |
12/18/23 09:38 | 12/15/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Butera Salvatore Thomas | NV | O | CEO - Vo | P | 8 | 0.7700 | 0 | 10 | 4 | 268 | D | | | | | | | | | | | | | | |
12/14/23 09:11 | 12/13/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Rootsaert Rodney Gerard | NV | O | Secretar | P | 6 | 0.6000 | 0 | 10 | 1 | 1,086 | D | | | | | | | | | | | | | | |
12/11/23 08:51 | 12/8/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Reynolds Cameron John | NV | DO | P,CEO | P | 7 | 0.6700 | 0 | 10 | 0 | 2,746 | D | | | | | | | | | | | | | | |
12/6/23 17:21 | 12/6/23 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sandford Nicole | TX | DO | P,CEO | P | 17 | 3.36 | 0 | 5 | 9 | 59 | D | | | | | | | | | | | | | | |
12/1/23 17:44 | 11/30/23 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Gelhaus Ken | CA | O | Chief Co | P | 6 | 1.73 | 0 | 4 | 19 | 23 | D | | | | | | | | | | | | | | |
11/28/23 09:39 | 11/27/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Innes Guy Archibald | NV | D | | P | 15 | 0.7700 | 0 | 20 | 1 | 2,601 | D | | | | | | | | | | | | | | |
11/28/23 09:39 | 11/27/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Futcher Edward | NV | D | | P | 7 | 0.8000 | 0 | 9 | 2 | 428 | D | | | | | | | | | | | | | | |
11/27/23 10:28 | 11/24/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Innes Guy Archibald | NV | D | | P | 8 | 0.7600 | 0 | 10 | 0 | 2,581 | D | | | | | | | | | | | | | | |
11/24/23 11:06 | 11/22/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Innes Guy Archibald | NV | D | | P | 14 | 0.7100 | 0 | 20 | 1 | 2,571 | D | | | | | | | | | | | | | | |
11/17/23 10:01 | 11/16/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Butera Salvatore Thomas | NV | O | CEO - Vo | P | 8 | 0.8100 | 0 | 10 | 4 | 258 | D | | | | | | | | | | | | | | |